Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Intranasal Ketamine Related Changes in Attentional Brain Networks With Functional and Structural MRI: a Placebo Controlled, Randomized, Cross-over Trial

NCT05320120 is registered in ClinicalTrials.gov with Rupert Lanzenberger as lead sponsor.

NCT NCT05320120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05320120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Intranasal Ketamine Related Changes in Attentional Brain Networks With Functional and Structural MRI: a Placebo Controlled, Randomized, Cross-over Trial
Lead sponsor
Rupert Lanzenberger
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2022
Completion date
June 21, 2023
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ketamine treatment